Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changchun Brother Biotech is a Chinese biopharmaceutical company specializing in the research, development, and production of biochemical drugs and diagnostic reagents. The company is primarily recognized for its expertise in protein purification, producing high-purity Thrombin and Hyaluronidase for clinical use. Based in the Changchun High-tech Industrial Development Zone, it operates GMP-certified manufacturing facilities that supply both finished dosage forms and raw materials. Their products are widely used in surgical procedures to control capillary bleeding and to enhance the absorption and dispersion of other injected drugs. The company serves both the domestic Chinese healthcare market and international diagnostic industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changchun Brother Biotech.